Induction by lenalidomide and dexamethasone combination increases regulatory cells of patients with previously untreated multiple myeloma

Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function

(2010) A. K. Gandhi et al.   CURRENT CANCER DRUG TARGETS

Significantly reduced regulatory T cell population in patients with untreated multiple myeloma

(2010) Ritu Gupta et al.   LEUKEMIA RESEARCH

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma

(2009) H Quach et al.   LEUKEMIA

CD4+CD25+ Regulatory T Cells Suppress Mast Cell Degranulation and Allergic Responses through OX40-OX40L Interaction

(2008) Giorgia Gri et al.   IMMUNITY

Treatment of newly diagnosed myeloma

(2008) A Palumbo et al.   LEUKEMIA

Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells

(2008) M C Minnema et al.   LEUKEMIA